Dr. Tian Zhang discusses tivozanib for advanced kidney cancer

Tian Zhang, MD, associate professor at UT Southwestern Medical Center, discusses the FDA-approved therapy tivozanib (Fotivda) for patients with relapsed or refractory advanced renal cell carcinoma, including ongoing trials further exploring the agent.